Authors


Denise Anthony, PhD

Latest:

Patient-Centered Communication, Disparities, and Patient Portals in the US, 2017-2022

From 2017 to 2022, patients with better communication with providers were more likely to report being offered and accessing a patient portal, but disparities persist.


Jianhui Xu, PhD

Latest:

Part D Beneficiaries’ Incentives and Responses Under Preferred Pharmacy Networks

Under preferred pharmacy networks, unsubsidized Part D beneficiaries faced substantial incentives and moderately switched toward preferred pharmacies, whereas subsidized beneficiaries were insulated and demonstrated little switching.


Karl Rubio, MIA

Latest:

Health Systems and Telemedicine Adoption for Diabetes and Hypertension Care

Small practices reduced their use of telemedicine during early stages of the COVID-19 pandemic. Technical support may help expand and maintain telemedicine in small practices.


Angela Boykin | Image Credit: Blue Cross Blue Shield North Carolina
Angela Boykin

Latest:

Contributor: North Carolinians Worked Together to Enact Medicaid Expansion. Our Collaboration Can’t End Now.

The sustained, collaborative effort to expand Medicaid will improve the lives of working North Carolinians who, prior to enactment, earned too much to qualify for Medicaid, but not enough to afford insurance on the marketplace.


Ann S. O’Malley, MD, MPH

Latest:

Incorporating Health IT Into Primary Care Transformation

Longitudinal evaluation of an advanced primary care reform effort found some improvements in health information technology (IT) offerings and use as well as opportunities to improve future collaboration.


Tricia Neuman, ScD

Latest:

Trends in Medicare Part D Coverage of Generics With Equivalent Brand-Name Drugs

High-tier generic drug placement in Medicare Part D has increased over time, but it may be related to a drug’s clinical profile and availability of substitutes rather than preferred brand-name drug coverage.


Jeffrey Marr, BA

Latest:

Traditional Medicare Supplemental Insurance and the Rise of Medicare Advantage

Rising Medicare Advantage enrollment occurred alongside declines in enrollment in traditional Medicare with employer-sponsored supplemental coverage and traditional Medicare without supplemental coverage.


Paige Kilian, MD

Latest:

Contributor: It’s About Time to Realize the Full Potential of Data in Health Care

Promoting health equity isn’t only about consideration of underlying health risks; it’s also about using that data to inform population care as well as give clinicians and their teams more time with the patient in front of them.


Elan Gada, MD

Latest:

Unfulfilled Home Health Referrals Lead to Higher Mortality Among Medicare Advantage Members

Medicare Advantage members referred to home health after acute hospitalization who did not receive home health services had higher mortality at 30, 90, and 180 days.


Kaury Kucera, PhD

Latest:

Safety vs Price in the Generic Drug Market: Metformin

The generic drug market focuses on price. However, multiple generic metformin drugs have been recalled due to poor drug quality. The authors examine price and quality after these recalls.


Hongyang Zhou, BS

Latest:

Patient Satisfaction With Letter-Based Communication of LCS Pulmonary Nodule Results

Patients were satisfied with receiving their lung cancer screening (LCS) pulmonary nodule results via letter and considered the amount of information provided in the letter appropriate.


Matthew Davids, MD, MMSc

Latest:

Impact of Patient-Reported Outcomes and Real-World Evidence in CLL and MCL

Panelists discuss how patient-reported outcomes and real-world evidence influence clinical decision-making when selecting Bruton tyrosine kinase (BTK) inhibitors for the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).


Diana Isaacs, PharmD

Latest:

Harnessing AI for Population Health: A Call to Action for Policy Makers and Health Care Leaders

The authors detail how artificial intelligence could be used in primary, secondary, and tertiary prevention to improve health outcomes and provide better value-based care.


Sophia Humphreys, PharmD, MHA, BCBBS

Latest:

Private Label Biosimilars

The expert panel discusses the greater potential for private label biosimilars.


John R. Litaker, PhD, MSc, MMedSc

Latest:

A Cue-to-Action Pilot Project to Increase Screening Mammography

A targeted cue-to-action campaign of outreach, education, and incentive can improve uptake of screening mammography.


Matthew J. Trombley, PhD

Latest:

An Analysis of Medicare Accountable Care Organization Expense Reports

The authors of this study examined expense reports to understand how participants in Medicare’s Accountable Care Organization Investment Model spent to achieve program goals.


Evangelia Vlachou, MD

Latest:

Enfortumab Vedotin With or Without Pembrolizumab Delivers Promising Responses for Upper Tract Urothelial Cancer

Enfortumab vedotin with or without pembrolizumab offers disease control benefits for patients with upper tract urothelial cancer, said Evangelia Vlachou, MD, of Johns Hopkins Medicine.


Debasish Mohapatra, MD

Latest:

Clinical Profile of COVID-19 Infection in Postvaccination Individuals

This article describes the findings of an observational study carried out in India to examine the clinical profile of individuals detected to be COVID-19 positive post vaccination.



Zachary Villaverde, BS

Latest:

Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease

Patients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it.


Chung-Ting Chen, MD, MS

Latest:

Association Between Screening for Suspected COVID-19 Cases and Outcomes of Patients Revisiting the Emergency Department

Patients who revisit the emergency department shortly after discharge are at high risk for complications and death, exacerbated by COVID-19 screening workload. Detection efforts impact outcomes.


Andrea Millman, MA

Latest:

Primary Care Video and Telephone Telemedicine During the COVID-19 Pandemic: Treatment and Follow-up Health Care Utilization

Telephone visits may offer a simple and convenient option to address patient primary care needs without raising safety concerns.



Devin M. Mann, MD

Latest:

The “New” New Normal: Changes in Telemedicine Utilization Since COVID-19

Telemedicine utilization has declined since the peak of the COVID-19 pandemic, but non–primary care specialties continue to see an increase in moderate- and high-complexity telemedicine visits.


Derek van Amerongen, MD, MS

Latest:

Concluding Remarks: Impact of Alzheimer Disease, Promising Treatments in Development, and Future Outlook

Looking to the future of Alzheimer disease treatment, the panel discusses key takeaways on the evolving therapeutic landscape.


Mark Supino, MD

Latest:

People Experiencing Homelessness in Miami: Insurance Enrollment Rates, Hypertension Trends

People experiencing homelessness face significant barriers to health care access, leading to higher rates of hypertension even among those with health insurance.


Heather M. Byrne, MPA-HSA, CNMT

Latest:

Eliminating Defects in Value: Turnaround of an MSSP ACO

A health system transformational leadership framework and management system made visible and eliminated defects in value and was associated with reduced annual Medicare expenditures and increased quality between 2017 and 2020.


Chris Wallick, PharmD, MS

Latest:

Baloxavir vs Oseltamivir: Reduced Utilization and Costs in Influenza

Baloxavir, compared with oseltamivir, was associated with lower health care resource utilization and costs in patients with influenza, particularly those at high risk of secondary complications.


Kandice A. Kapinos, PhD

Latest:

Differences in Savings and Quality by Type of ACO Model

2016-2018 Next Generation Accountable Care Organization (ACO) and Medicare Shared Savings Program cost and quality data show similar performance, suggesting that increasing financial risk to health systems may not affect performance.


Georgianna Mann, PhD

Latest:

Impact of Food Affordability on Diabetes-Related Preventable Hospitalization

Medicaid enrollees residing in counties with greater food affordability had lower odds of preventable hospitalization related to diabetes.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo